Literature DB >> 25849851

Utility of ferritin as a predictor of the patients with Kawasaki disease refractory to intravenous immunoglobulin therapy.

Noboru Yamamoto1,2, Kaoru Sato1, Takayuki Hoshina2, Masumi Kojiro1, Koichi Kusuhara2.   

Abstract

OBJECTIVES: The aim of this study is to investigate whether ferritin can be a useful marker for the prediction of the patients with Kawasaki disease (KD) refractory to initial intravenous immunoglobulin (IVIG) therapy.
METHODS: This retrospective study enrolled 85 patients with KD hospitalized at Kitakyushu General Hospital during 2010-2014. These patients were divided into IVIG responders (n = 57) and non-responders (n = 28). Serum ferritin levels and the scoring systems for the prediction of non-responsiveness to initial IVIG therapy were compared between these two groups.
RESULTS: Serum ferritin level was significantly elevated in non-responders (p = 0.010). The area under the receiver-operating characteristics curve was 0.674, and the sensitivity and specificity in more than 165 ng/ml of serum ferritin level were 70.4% and 63.2%, respectively. In two of the three prediction scoring systems, non-responders also showed significantly higher scores than responders, but many non-responders had low scores of these scoring systems. More than half of the patients with a low score of these scoring systems had high serum ferritin level (≥ 165 ng/ml).
CONCLUSIONS: Serum ferritin level might be a useful marker for the prediction of non-responsiveness to initial IVIG therapy and could be an important complementary marker to the prediction scoring systems.

Entities:  

Keywords:  Ferritin; Intravenous immunoglobulin therapy; Refractory Kawasaki disease

Mesh:

Substances:

Year:  2015        PMID: 25849851     DOI: 10.3109/14397595.2015.1038430

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  7 in total

1.  Serum ferritin as an indicator of the development of encephalopathy in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.

Authors:  Masaki Shimizu; Natsumi Inoue; Mondo Kuroda; Hitoshi Irabu; Maiko Takakura; Hisashi Kaneda; Naotoshi Sugimoto; Kazuhide Ohta; Akihiro Yachie
Journal:  Clin Exp Nephrol       Date:  2017-03-10       Impact factor: 2.801

Review 2.  Vasculitis Pathogenesis: Can We Talk About Precision Medicine?

Authors:  Seza Ozen; Ezgi Deniz Batu
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

3.  Serum Ferritin as a Diagnostic Biomarker for Kawasaki Disease.

Authors:  Sung Hoon Kim; Eun Song Song; Somy Yoon; Gwang Hyeon Eom; Gaeun Kang; Young Kuk Cho
Journal:  Ann Lab Med       Date:  2021-05-01       Impact factor: 3.464

4.  Serum ferritin as a crucial biomarker in the diagnosis and prognosis of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease: A systematic review and meta-analysis.

Authors:  Huai Wen; Marady Hun; Mingyi Zhao; Phanna Han; Qingnan He
Journal:  Front Med (Lausanne)       Date:  2022-08-10

5.  Incomplete Refractory Kawasaki Disease in an Infant-A Case Report and a Review of the Literature.

Authors:  Cristina O Mărginean; Lorena E Meliț; Liliana Gozar; Cristian Dan Mărginean; Maria O Mărginean
Journal:  Front Pediatr       Date:  2018-07-27       Impact factor: 3.418

6.  Importance of Serum Ferritin Level for Early Diagnosis and Differentiation in Patients with Kawasaki Disease with Macrophage Activation Syndrome.

Authors:  Da Eun Roh; Jung Eun Kwon; Hee Joung Choi; Yeo Hyang Kim
Journal:  Children (Basel)       Date:  2021-03-31

7.  Update on the COVID-19-associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2.

Authors:  Davinder Singh-Grewal; Ryan Lucas; Kristine McCarthy; Allen C Cheng; Nicholas Wood; Genevieve Ostring; Philip Britton; Nigel Crawford; David Burgner
Journal:  J Paediatr Child Health       Date:  2020-07-31       Impact factor: 1.929

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.